Changes for page Methodology

Last modified by manuelmenendez on 2025/03/14 08:31
From version 22.1
edited by manuelmenendez
on 2025/02/15 12:55
Change comment: There is no comment for this version
To version 23.1
edited by manuelmenendez
on 2025/02/15 12:55
Change comment: There is no comment for this version

Summary

Details

Page properties
Content
... ... @@ -11,7 +11,7 @@
11 11  |=**Category**|=**Description**
12 12  |**Molecular Biomarkers**|Omics-based markers (genomic, transcriptomic, proteomic, metabolomic, lipidomic)
13 13  |**Neuroimaging Biomarkers**|Structural (MRI, CT), Functional (fMRI, PET), Molecular Imaging (tau, amyloid, α-synuclein)
14 -|**Fluid Biomarkers**|CSF, plasma, blood-based markers for tau, amyloid, α-synuclein, TDP-43, GFAP, NfL
14 +|**Fluid Biomarkers**|CSF, plasma, blood-based markers for tau, amyloid, α-synuclein, TDP-43, GFAP, NfL, autoantiboides
15 15  |**Neurophysiological Biomarkers**|EEG, MEG, evoked potentials (ERP), sleep-related markers
16 16  |**Digital Biomarkers**|Gait analysis, cognitive/speech biomarkers, wearables data, EHR-based markers
17 17  |**Clinical Phenotypic Markers**|Standardized clinical scores (MMSE, MoCA, CDR, UPDRS, ALSFRS, UHDRS)